Prolocor Inc | WebDisclosure

Basculer en Français

8295	Companies
114809	Keywords
55260	Articles
62422	Press releases

Home
Companies
Prolocor Inc

BRIEF

published on 10/21/2024 at 17:05, 30 days 16 hours ago

Prolocor Unveils Results of Multicenter Study on Cardiovascular Risk in JACC

Prolocor PFCG® Test Cardiovascular Risk Antithrombotic Treatment JACC Publication Individualized Therapy
BRIEF

published on 10/21/2024 at 17:05, 30 days 16 hours ago

Prolocor dévoile les résultats d'une étude multicentrique sur le risque cardiovasculaire au JACC

Test Prolocor PFCG® Risque Cardiovasculaire Traitement Antithrombotique Publication Du JACC Thérapie Individualisée
PRESS RELEASE

published on 10/21/2024 at 17:00, 30 days 16 hours ago

Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
Prolocor, Inc. announces publication of results from a confirmatory 800 patient ACS trial in JACC, showing a >2-fold predictive value for heart attack, stroke, and death. The Prolocor pFCG® test supports individualized antiplatelet therapy

Prolocor Inc. JACC Publication ACS Trial PFCG Test Antiplatelet Therapy
BRIEF

published on 09/05/2024 at 14:05, 2 months 15 days ago

Prolocor and Slingshot Biosciences Announce Publication in Bioanalysis

Prolocor PFCG® Test Thrombosis Prognosis TruCytes Cell Mimics Heart Attack Risk Precision Diagnostics
BRIEF

published on 09/05/2024 at 14:05, 2 months 15 days ago

Prolocor et Slingshot Biosciences annoncent une publication dans Bioanalysis

Diagnostic De Précision Test Prolocor PFCG® Pronostic De Thrombose Les Imitations Cellulaires TruCytes Risque De Crise Cardiaque
PRESS RELEASE

published on 09/05/2024 at 14:00, 2 months 15 days ago

Prolocor and Slingshot Biosciences Announce Publication of 'Assessing Prognosis by Quantifying FcγRIIa on Fixed Platelets' in Bioanalysis
Study in Bioanalysis shows Prolocor pFCG® test as reliable tool for thrombosis risk assessment with TruCytes cell mimics, accurate and precise. Partnership between Prolocor Inc. and Slingshot Biosciences

Partnership Prolocor PFCG® Test TruCytes Cell Mimics Thrombosis Risk Bioanalysis Study
BRIEF

published on 02/27/2024 at 15:00, 8 months 22 days ago

Prolocor lève 1,7 million de dollars pour un programme de diagnostic précis du risque de thrombose

Financement Innovation Médicale Prolocor Thrombose Diagnostic
BRIEF

published on 02/27/2024 at 15:00, 8 months 22 days ago

Prolocor raises $1.7 million for an accurate thrombosis risk diagnostic program

Funding Prolocor Thrombosis Medical Innovation Diagnostic
PRESS RELEASE

published on 02/27/2024 at 15:00, 8 months 22 days ago

Prolocor Announces $1.7 Million in Bridge Funding
Prolocor, Inc. raises $1.7 million in bridge financing to advance precision diagnostic test for predicting thrombosis risk. Funding from GPG Ventures and Labcorp Venture Fund

Bridge Financing Prolocor Inc. Precision Diagnostic Test Thrombosis Risk Prediction GPG Ventures
BRIEF

published on 02/20/2024 at 15:00, 9 months ago

Prolocor, Inc. Présente une Percée dans le Diagnostic des Risques de Thrombose

Innovation Médicale Prolocor Thrombose Diagnostic De Précision Cardiologie

Accesswire

Published on 11/21/2024 at 09:00, 49 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 14 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 24 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 49 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 49 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:01, 48 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 49 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 49 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 34 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 39 minutes ago

KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 51 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 51 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 51 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 42 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 29 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE